雾化高剂量皮质类固醇作为喘恶化成人的附加治疗:一项随机对照试验
Kumpol Kornthatchapong1, Nat Chatchairatanavej2, Nattaya Chormai2
1Department of Emergency Medicine, Faculty of Medicine, Thammasat University, Khlong Luang, Pathumthani, Thailand kump29@gmail.com.
Emergency medicine journal : EMJ
|December 18, 2024
概括
高剂量吸入性皮质类固醇 (HDICS) 显著减少了成人喘恶化急诊室 (ED) 停留时间. 这种附加疗法在改善患者流动而不会影响入院率方面表现有前途.
科学领域:
- 紧急医疗 紧急医疗
- 肺部病理学 肺部病理学
- 临床药理学 临床药理学
背景情况:
- 对于高剂量吸入性皮质类固醇 (HDICS) 治疗成人喘恶化存在有限的证据.
- 在急诊室 (ED) 的急性喘恶化需要有效的治疗策略.
研究的目的:
- 为了比较HDICS作为附加疗法的有效性与在成年人中急性喘恶化症的标准治疗.
主要方法:
- 进行了一项单中心,三盲,随机对照试验.
- 成年患者接受了 nebulized HDICS (布塞索尼德9000微克) 或安慰剂,结合标准护理.
- 主要结局包括ED停留时间,住院和ED复诊率.
主要成果:
- 在HDICS组,ED停留时间显著缩短 (平均差异为-133.6分钟).
- 在HDICS组中,更高比例的患者在8小时和16小时内被送回家.
- 没有观察到住院,ED复诊或其他次要结果的显著差异.
结论:
- HDICS可能是成年人喘恶化标准治疗的有益补充疗法.
- 这种方法可能会减少急诊室停留的时间.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
217
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
217
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management
348
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
348
Antiasthma Drugs: β2-Adrenoceptor Agonists
232
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
232
Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237


